- €2.59bn
- €4.07bn
- €95.93m
- 57
- 40
- 71
- 57
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26 | 29.6 | 44.3 | 84.8 | 95.9 |
Cost of Revenue | |||||
Gross Profit | 22.2 | 25.3 | 37.7 | 69.6 | 90.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -226 | -390 | -732 | 200 | -22.8 |
Operating Profit | 252 | 419 | 777 | -116 | 119 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 238 | 411 | 764 | -143 | 113 |
Provision for Income Taxes | |||||
Net Income After Taxes | 206 | 371 | 650 | -123 | 87.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 206 | 371 | 650 | -123 | 87.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 206 | 371 | 650 | -123 | 87.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 10.4 | 17.5 | 29.5 | -5.49 | 3.2 |
Dividends per Share |